litlas
ログインアカウント作成

Leif Mosekilde

1977–2016 年に発表

138
論文数
23,993
被引用数
100
h 指数
138
i10 指数

被引用数

Leif Mosekilde の年別被引用数1978 年: 被引用 7 件1979 年: 被引用 2 件1980 年: 被引用 2 件1981 年: 被引用 5 件1982 年: 被引用 12 件1983 年: 被引用 15 件1984 年: 被引用 13 件1985 年: 被引用 19 件1986 年: 被引用 15 件1987 年: 被引用 14 件1988 年: 被引用 22 件1989 年: 被引用 20 件1990 年: 被引用 53 件1991 年: 被引用 34 件1992 年: 被引用 36 件1993 年: 被引用 75 件1994 年: 被引用 53 件1995 年: 被引用 61 件1996 年: 被引用 50 件1997 年: 被引用 69 件1998 年: 被引用 60 件1999 年: 被引用 62 件2000 年: 被引用 88 件2001 年: 被引用 71 件2002 年: 被引用 64 件2003 年: 被引用 88 件2004 年: 被引用 106 件2005 年: 被引用 143 件2006 年: 被引用 142 件2007 年: 被引用 138 件2008 年: 被引用 212 件2009 年: 被引用 184 件2010 年: 被引用 207 件2011 年: 被引用 195 件2012 年: 被引用 206 件2013 年: 被引用 182 件2014 年: 被引用 196 件2015 年: 被引用 180 件2016 年: 被引用 199 件2017 年: 被引用 204 件2018 年: 被引用 169 件2019 年: 被引用 559 件2020 年: 被引用 585 件2021 年: 被引用 411 件2022 年: 被引用 271 件2023 年: 被引用 174 件2024 年: 被引用 346 件2025 年: 被引用 140 件2026 年: 被引用 1 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,764 件、この内訳の 24.2%イギリス: 引用元論文 594 件、この内訳の 8.1%デンマーク: 引用元論文 503 件、この内訳の 6.9%イタリア: 引用元論文 441 件、この内訳の 6.1%中国: 引用元論文 317 件、この内訳の 4.3%カナダ: 引用元論文 305 件、この内訳の 4.2%オーストラリア: 引用元論文 297 件、この内訳の 4.1%ドイツ: 引用元論文 254 件、この内訳の 3.5%フランス: 引用元論文 251 件、この内訳の 3.4%オランダ: 引用元論文 229 件、この内訳の 3.1%スイス: 引用元論文 205 件、この内訳の 2.8%ベルギー: 引用元論文 143 件、この内訳の 2%
0%24.2%その他 27.3%

機関

分野

  • Medicine78.7%
  • Biochemistry, Genetics and Molecular Biology11.9%
  • Neuroscience2.6%
  • Nursing1.5%
  • Engineering1.3%
  • Psychology0.9%
  • その他3.1%

トピック

  • Bone health and osteoporosis research11.7%
  • Vitamin D Research Studies7.3%
  • Bone health and treatments5.5%
  • Parathyroid Disorders and Treatments5.4%
  • Bone Metabolism and Diseases4.5%
  • Thyroid and Parathyroid Surgery2.7%
  • その他62.9%

共著者

全論文

検索で開く
  1. Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow-up study

    著者: Line Underbjerg, Tanja Sikjær, Leif Mosekilde, Lars Rejnmark - Journal of Bone and Mineral Research 2013 被引用: 310

  2. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus

    著者: Aliya Khan, David A. Hanley, René Rizzoli, Jens Bollerslev, J. E. M. Young, Lars Rejnmark, Rajesh V. Thakker, P D'Amour, Terri Paul, Stan Van Uum, M. Zakaria Shrayyef, David Goltzman, S. Kaiser, Natalie E. Cusano, Roger Bouillon, Leif Mosekilde, A W Kung, Sudhaker D. Rao, Sanjay Kumar Bhadada, B.L. Clarke, Jue Liu, Quan‐Yang Duh, E. Michael Lewiecki, Francisco Bandeira, Richard Eastell, Claudio Marcocci, Shonni J. Silverberg, Robert Udelsman, K. Shawn Davison, John T. Potts, Maria Luisa Brandi, John P. Bilezikian - Osteoporosis International 2016 被引用: 538

  3. Postsurgical Hypoparathyroidism—Risk of Fractures, Psychiatric Diseases, Cancer, Cataract, and Infections

    著者: Line Underbjerg, Tanja Sikjær, Leif Mosekilde, Lars Rejnmark - Journal of Bone and Mineral Research 2014 被引用: 259

  4. The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study

    著者: Line Underbjerg, Tanja Sikjær, Leif Mosekilde, Lars Rejnmark - Journal of Bone and Mineral Research 2015 被引用: 243

  5. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research

    著者: John P. Bilezikian, Aliya Khan, John T. Potts, Maria Luisa Brandi, B.L. Clarke, Dolores Shoback, Harald Jüppner, P D'Amour, John Fox, Lars Rejnmark, Leif Mosekilde, Mishaela R. Rubin, David W. Dempster, Rachel I. Gafni, Michael T. Collins, J. Sliney, James M. Sanders - Journal of Bone and Mineral Research 2011 被引用: 616

  6. Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study

    著者: Michael Mannstadt, B.L. Clarke, Tamara Vokes, Maria Luisa Brandi, L. Ranganath, William D. Fraser, Péter Lakatos, László Bajnok, Roger J. Garceau, Leif Mosekilde, Hjalmar Lagast, Dolores Shoback, John P. Bilezikian - The Lancet Diabetes & Endocrinology 2013 被引用: 303

  7. Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers

    著者: Ellen‐Margrethe Hauge, Dorte Qvesel, Erik Fink Eriksen, Leif Mosekilde, F. Melsen - Journal of Bone and Mineral Research 2001 被引用: 385

  8. Fractures in Patients with Hyperthyroidism and Hypothyroidism: A Nationwide Follow-Up Study in 16,249 Patients

    著者: Peter Vestergaard, Leif Mosekilde - Thyroid 2002 被引用: 293

  9. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

    著者: Peter Vestergaard, Lars Rejnmark, Leif Mosekilde - Diabetologia 2005 被引用: 558

  10. The Metabolic Syndrome Is Frequent in Klinefelter’s Syndrome and Is Associated With Abdominal Obesity and Hypogonadism

    著者: Anders Bojesen, Kurt Kristensen, Niels Birkebæk, Jens Fedder, Leif Mosekilde, Eric Bennett, Peter Laurberg, Jan Frystyk, Allan Flyvbjerg, Jens Sandahl Christiansen, Claus Højbjerg Gravholt - Diabetes Care 2006 被引用: 318

  11. Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes

    著者: Peter Vestergaard, Lars Rejnmark, Leif Mosekilde - Calcified Tissue International 2008 被引用: 282

  12. Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop

    著者: Shonni J. Silverberg, E. Michael Lewiecki, Leif Mosekilde, Munro Peacock, Mishaela R. Rubin - The Journal of Clinical Endocrinology & Metabolism 2009 被引用: 689

  13. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency – a double-blind, randomized, placebo-controlled trial

    著者: Ulla Kampmann, Leif Mosekilde, Claus Bogh Juhl, Niels Møller, Britt Christensen, Lars Rejnmark, Louise Wamberg, L. Ørskov - Metabolism 2014 被引用: 141

  14. Vitamin D and the elderly

    著者: Leif Mosekilde - Clinical Endocrinology 2005 被引用: 422

  15. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study.

    著者: Lars Frost, Peter Vestergaard, Leif Mosekilde - 2004 被引用: 304

  16. Effects of PTH(1–84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial

    著者: Tanja Sikjær, Lars Rolighed, A. Hess, Anders Fuglsang‐Frederiksen, Leif Mosekilde, Lars Rejnmark - Osteoporosis International 2014 被引用: 131

  17. The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: A randomized, placebo-controlled study

    著者: Tanja Sikjær, Lars Rejnmark, Lars Rolighed, Lene Heickendorff, Leif Mosekilde, the Hypoparathyroid Study Group - Journal of Bone and Mineral Research 2011 被引用: 189

  18. Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial

    著者: Anne Kristine Amstrup, Tanja Sikjær, Lene Heickendorff, Leif Mosekilde, Lars Rejnmark - Journal of Pineal Research 2015 被引用: 155

  19. Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in Hypothyroidism

    著者: Tanja Sikjær, Emil Moser, Lars Rolighed, Line Underbjerg, Lise Sofie Bislev, Leif Mosekilde, Lars Rejnmark - Journal of Bone and Mineral Research 2016 被引用: 106

  20. Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture

    著者: Peter Vestergaard, Lars Rejnmark, Leif Mosekilde - Calcified Tissue International 2006 被引用: 373

  21. Hyperthyroidism, Bone Mineral, and Fracture Risk—A Meta-Analysis

    著者: Peter Vestergaard, Leif Mosekilde - Thyroid 2003 被引用: 304

  22. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone

    著者: Anders Bojesen, Niels Birkebæk, Kurt Kristensen, Lene Heickendorff, Leif Mosekilde, J. S. Christiansen, Claus Højbjerg Gravholt - Osteoporosis International 2010 被引用: 87

  23. Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark

    著者: Peter Vestergaard, Lars Rejnmark, Leif Mosekilde - Osteoporosis International 2004 被引用: 229

  24. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study

    著者: Charlotte Mollerup, Peter Vestergaard, Vibe Gedsø Frøkjær, Leif Mosekilde, Peer Christiansen, Mogens Blichert-Toft - BMJ 2002 被引用: 213